Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

Texas: LabNow Lands $20 Million for AIDS Work

November 14, 2007

Austin-based LabNow Inc. has secured $20 million in investments to help the biotechnology firm establish a manufacturing line and conduct clinical trials on a device that can analyze a drop of blood. Though the technology can be used for many diagnostic purposes, the company is seeking to win Food and Drug Administration approval for monitoring CD4 lymphocytes, which are a key factor in assessing whether HIV drug treatments are working or need adjustments. LabNow CEO Rick Hawkins said he hopes to sell the device to nonprofits, universities, and businesses in Asia and Africa. The toaster-size device is a lower-cost alternative to current equipment and could transform the way HIV is managed, he said.

Back to other news for November 2007

Adapted from:
Austin American-Statesman
11.12.2007; Lilly Rockwell


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News

Tools
 

Advertisement